Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

ASH 2022 Conference Coverage
N

ASH 2022 Maintenance Therapy Cessation for Sustained MRD Negative MM Patients

By ASH 2022 Conference Coverage FEATURING Neha Korde
By ASH 2022 Conference Coverage FEATURING Neha Korde
399 views
December 21, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Myeloma
16:42
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…

Feat. H. Hashmi
15:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Frontline Treatment for High-Risk MM - Personalized?

Feat. S. Usmani
31:51
Indy Hematology Review

Managing Newly Diagnosed MM in 2023

Feat. S. Usmani
15:53
Indy Hematology Review

DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remissi…

Feat. S. Usmani
10:08
ASH 2022 Conference Coverage

ASH 2022 Maintenance Therapy Cessation for Sustained MRD Negative MM…

Feat. N. Korde
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
20:17
Rush University Medical Center

High-Risk Myeloma: Failures and Future Directions

Feat. S. Usmani
11:51
Memorial Sloan Kettering Cancer Center

Aiming for Minimal Residual Disease Negative Status in all Myeloma P…

Feat. O. Landgren
19:16
Memorial Sloan Kettering Cancer Center

Should Smoldering Myeloma Be Treated?

Feat. O. Landgren
47:00
Memorial Sloan Kettering Cancer Center

Common Symptoms and Presentations of Multiple Myeloma to Primary Car…

Feat. O. Landgren